Our firm is investigating cases of serious bleeding as a result of taking Xarelto.
Xarelto is an anticoagulant, most commonly known as blood thinners, developed by Bayer and Janssen Pharmaceuticals. This drug works by blocking clotting proteins in your blood. In 2011, the FDA approved Xarelto for use in preventing blood clots after knee and hip replacement surgeries and to prevent stroke in patients suffering from atrial fibrillation (irregular heartbeat). Since then, the FDA has fast tracked the approval for Xarelto to treat deep vein thrombosis (blood clots deep within the body) and pulmonary embolism (blood clots in the lungs).
The most dangerous side effect of Xarelto is severe and excessive bleeding. Unlike older anticoagulants such as warfarin, there is no antidote for bleeding associated with taking Xarelto. Because this bleeding cannot be effectly counteracted, it will occur until the drug is flushed out of the system. This can lead to hospitalization and death.
There is new evidence that suggests that the manufacturers of Xarelto were aware of the potentially life threatening side effects of this drug when it hit the market. If you or a loved one has taken Xarelto and experienced any adverse side effects from this drug, we urge you to contact our firm.
For more information about our Defective Drugs & Devices practice area, click here.